Miaofen G. Hu

1.5k total citations
28 papers, 1.2k citations indexed

About

Miaofen G. Hu is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Miaofen G. Hu has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Physiology. Recurrent topics in Miaofen G. Hu's work include Cancer-related Molecular Pathways (10 papers), Adipose Tissue and Metabolism (6 papers) and Epigenetics and DNA Methylation (4 papers). Miaofen G. Hu is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Adipose Tissue and Metabolism (6 papers) and Epigenetics and DNA Methylation (4 papers). Miaofen G. Hu collaborates with scholars based in United States, China and Japan. Miaofen G. Hu's co-authors include Guo‐fu Hu, Philip W. Hinds, Guo-fu Hu, Takanori Tsuji, Soichiro Ibaragi, Kaori Shima, Nelson E. Brown, Akira Sasaki, Miki Katsurano and Shuping Li and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Miaofen G. Hu

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miaofen G. Hu United States 16 675 466 259 157 132 28 1.2k
Ronald J. Bernardi United States 13 673 1.0× 291 0.6× 168 0.6× 137 0.9× 110 0.8× 14 1.3k
Vihren N. Kolev United States 18 851 1.3× 403 0.9× 204 0.8× 163 1.0× 182 1.4× 39 1.4k
Victor Stastny United States 15 917 1.4× 443 1.0× 324 1.3× 141 0.9× 169 1.3× 24 1.4k
Victoria Hill United States 17 729 1.1× 338 0.7× 220 0.8× 137 0.9× 158 1.2× 23 1.2k
Roberto Bellelli United Kingdom 16 1.1k 1.6× 283 0.6× 245 0.9× 135 0.9× 97 0.7× 23 1.3k
Mona Shehata United Kingdom 16 768 1.1× 526 1.1× 269 1.0× 122 0.8× 130 1.0× 24 1.3k
Jan van Riggelen United States 17 1.3k 2.0× 483 1.0× 333 1.3× 77 0.5× 153 1.2× 20 1.7k
Hena R. Ashar United States 12 1.2k 1.7× 522 1.1× 380 1.5× 150 1.0× 115 0.9× 13 1.6k
James Koh United States 16 944 1.4× 800 1.7× 242 0.9× 143 0.9× 162 1.2× 35 1.5k
Takeharu Sakamoto Japan 22 587 0.9× 307 0.7× 566 2.2× 101 0.6× 108 0.8× 54 1.2k

Countries citing papers authored by Miaofen G. Hu

Since Specialization
Citations

This map shows the geographic impact of Miaofen G. Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaofen G. Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaofen G. Hu more than expected).

Fields of papers citing papers by Miaofen G. Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaofen G. Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaofen G. Hu. The network helps show where Miaofen G. Hu may publish in the future.

Co-authorship network of co-authors of Miaofen G. Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Miaofen G. Hu. A scholar is included among the top collaborators of Miaofen G. Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaofen G. Hu. Miaofen G. Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, Yongzhao Zhang, Jamie K. Hu, et al.. (2024). CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver. Nature Communications. 15(1). 1091–1091. 3 indexed citations
2.
Li, Wei, Jamie K. Hu, & Miaofen G. Hu. (2023). CDK6: an attractive therapeutic target for T-ALL/LBL. Expert Opinion on Therapeutic Targets. 27(11). 1087–1096. 2 indexed citations
4.
Cheng, Siyao, Yunxia Sun, Xiaofeng Yu, et al.. (2023). Hyperoside prevents high-fat diet-induced obesity by increasing white fat browning and lipophagy via CDK6-TFEB pathway. Journal of Ethnopharmacology. 307. 116259–116259. 19 indexed citations
5.
Sun, Yunxia, Siyao Cheng, Xiaofeng Yu, et al.. (2023). Acteoside improves adipocyte browning by CDK6-mediated mTORC1-TFEB pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(9). 159364–159364. 5 indexed citations
6.
Li, Wei, et al.. (2023). CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation. Frontiers in Molecular Biosciences. 10. 1146047–1146047. 5 indexed citations
7.
Liu, Fengming, Shirui Hou, Jamy C. Peng, et al.. (2022). A kinase-independent function of cyclin-dependent kinase 6 promotes outer radial glia expansion and neocortical folding. Proceedings of the National Academy of Sciences. 119(38). e2206147119–e2206147119. 6 indexed citations
8.
Caron, Nicolas, Emmanuelle C. Genin, Laurence Morel, et al.. (2018). Proliferation of hippocampal progenitors relies on p27-dependent regulation of Cdk6 kinase activity. Cellular and Molecular Life Sciences. 75(20). 3817–3827. 9 indexed citations
9.
Hou, Xiaoli, Yongzhao Zhang, Wei Li, et al.. (2018). CDK6 inhibits white to beige fat transition by suppressing RUNX1. Nature Communications. 9(1). 1023–1023. 55 indexed citations
10.
Gonçalves, Ana Katherine, Lev Silberstein, Shuping Li, et al.. (2016). Angiogenin Promotes Hematopoietic Regeneration by Dichotomously Regulating Quiescence of Stem and Progenitor Cells. Cell. 166(4). 894–906. 138 indexed citations
11.
Jena, Nilamani, Jinghao Sheng, Jamie K. Hu, et al.. (2015). CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia. Leukemia. 30(5). 1033–1043. 38 indexed citations
12.
Luo, Chi, Jinghao Sheng, Miaofen G. Hu, et al.. (2013). Loss of ARF Sensitizes Transgenic BRAFV600E Mice to UV-Induced Melanoma via Suppression of XPC. Cancer Research. 73(14). 4337–4348. 25 indexed citations
13.
Brown, Nelson E., Rinath Jeselsohn, Teeru Bihani, et al.. (2012). Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium. Cancer Research. 72(24). 6477–6489. 59 indexed citations
14.
Li, Shuping, Jinghao Sheng, Jamie K. Hu, et al.. (2012). Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis. 16(2). 387–404. 47 indexed citations
15.
Jeselsohn, Rinath, Nelson E. Brown, Lisa M. Arendt, et al.. (2010). Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis. Cancer Cell. 17(1). 65–76. 105 indexed citations
16.
Hu, Miaofen G., Amit Deshpande, Miriam Enos, et al.. (2009). A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis. Cancer Research. 69(3). 810–818. 96 indexed citations
17.
Monti, Daria Maria, Wenhao Yu, Elio Pizzo, et al.. (2009). Characterization of the angiogenic activity of zebrafish ribonucleases. FEBS Journal. 276(15). 4077–4090. 13 indexed citations
18.
Tsuji, Takanori, Soichiro Ibaragi, Kaori Shima, et al.. (2008). Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth. Cancer Research. 68(24). 10377–10386. 176 indexed citations
19.
Shintani, Satoru, Hiroe Ohyama, Xue Zhang, et al.. (2000). p12DOC-1 Is a Novel Cyclin-Dependent Kinase 2-Associated Protein. Molecular and Cellular Biology. 20(17). 6300–6307. 65 indexed citations
20.
Shintani, Satoru, Hiroe Ohyama, Xue Zhang, et al.. (2000). p12DOC-1 Is a Novel Cyclin-Dependent Kinase 2-Associated Protein. Molecular and Cellular Biology. 20(17). 6300–6307. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026